KyeongJin Kim

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 4

Top Topics

Embryonic Stem Cells

Top Venues

Nature communications

Experimental & molecular medicine

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Yelin Jeong, Ah-Reum Oh, Young Hoon Jung, HyunJoon Gi, Young Un Kim, KyeongJin Kim
Targeting E3 ubiquitin ligases and their adaptors as a therapeutic strategy for metabolic diseases. Experimental & molecular medicine (2023)
Sang Bae Lee, Luciano Garofano, Aram Ko, Fulvio D'Angelo, Brulinda Frangaj, Danika Sommer, Qiwen Gan, KyeongJin Kim, Timothy Cardozo, Antonio Iavarone, Anna Lasorella
Regulated interaction of ID2 with the anaphase-promoting complex links progression through mitosis with reactivation of cell-type-specific transcription. Nature communications 13 (1) (2022)
KyeongJin Kim, Jin Ku Kang, Young Hoon Jung, Sang Bae Lee, Raffaela Rametta, Paola Dongiovanni, Luca Valenti, Utpal B Pajvani
Adipocyte PHLPP2 inhibition prevents obesity-induced fatty liver. Nature communications 12 (1) (2021)
Junjie Yu, Changyu Zhu, Xiaobo Wang, KyeongJin Kim, Alberto Bartolomé, Paola Dongiovanni, Katherine P Yates, Luca Vittorio Valenti, Michele Carrer, Thorsten Sadowski, Li Qiang, Ira Tabas, Joel E Lavine, Utpal B Pajvani
Hepatocyte TLR4 triggers inter-hepatocyte Jagged1/Notch signaling to determine NASH-induced fibrosis. Science translational medicine 13 (599) (2021)